Back to top
more

Encompass Health (EHC)

(Delayed Data from NYSE)

$108.53 USD

108.53
1,272,979

-1.58 (-1.43%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $108.55 +0.02 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (62 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Encompass Health Q3 Earnings Beat on Higher Discharges, Stock Up 6.3%

by Zacks Equity Research

EHC's third-quarter results benefit from improved patient discharges. Higher operating expenses act as a partial offset.

Zacks Equity Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Humana Q3 Earnings Beat on Growing Premiums & Cost Management

by Zacks Equity Research

Better-than-expected Medicare Advantage membership aids HUM's third-quarter results.

Zacks Equity Research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Compared to Estimates, Encompass Health (EHC) Q3 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Encompass Health (EHC) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of 9.57% and 1.73%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock?

by Debanjana Dey

Improvement in RPT is likely to have boosted DaVita's top line in the third quarter.

Zacks Equity Research

Molina Healthcare Q3 Earnings Beat Estimates on Growing Premiums

by Zacks Equity Research

MOH's third-quarter results benefit from growing membership and rising premiums, partially offset by rising expenses.

Zacks Equity Research

Are Investors Undervaluing Encompass Health (EHC) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare

by Zacks Equity Research

Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare have been highlighted in this Industry Outlook article.

Debanjana Dey headshot

4 Stocks to Buy in an Evolving Outpatient Home Health Industry

by Debanjana Dey

Dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, AMED and ADUS are well-poised to gain.

Zacks Equity Research

Insights Into Encompass Health (EHC) Q3: Wall Street Projections for Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Encompass Health (EHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

Zacks Equity Research

EHC vs. ASTH: Which Stock Is the Better Value Option?

by Zacks Equity Research

EHC vs. ASTH: Which Stock Is the Better Value Option?

Zacks Equity Research

Encompass Health (EHC) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kaibalya Pravo Dey headshot

Bargain or Bust? Decoding Tenet Healthcare Stock's Lower Valuation

by Kaibalya Pravo Dey

THC is well-positioned to benefit from the growing demand for hospital services. Yet, rising costs can potentially squeeze its margin growth.

Zacks Equity Research

Elevance Health's Q3 Earnings Miss Due to Medicaid Redeterminations

by Zacks Equity Research

ELV's third-quarter earnings are hurt by declining membership in Medicaid and Medicare, partially offset by improved product revenues.

Zacks Equity Research

Will Encompass Health (EHC) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Encompass Health (EHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Here's Why Encompass Health (EHC) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Centene's Meridian Unit Wins Michigan Contract for HIDE SNP Plan

by Zacks Equity Research

CNC's Meridian subsidiary secures a contract to provide integrated Medicare and Medicaid services in Michigan through a new HIDE SNP program, which is expected to boost its member base and statewide presence.

Zacks Equity Research

DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

UnitedHealth Q3 Earnings Beat on Domestic Commercial Business

by Zacks Equity Research

UNH's third-quarter earnings benefit on the back of client wins in the Optum Rx sub-unit, partly offset by an elevated operating expense level.

Zacks Equity Research

Here's Why Encompass Health (EHC) is a Strong Growth Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Encompass Health (EHC) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Encompass Health (EHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Is Encompass Health (EHC) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.